Healthcare - Friday, December 18, 2009 15:32 - 0 Comments

Tiens Biotech Group USA Inc. TBV Shares Up 3.32% in Morning Session

Tiens Biotech Group (USA), Inc. announced financial results for the third quarter and nine months ended September 30, 2009. Revenue for the third quarter of 2009 was $9.4 million, compared to $26.2 million for the third quarter of 2008.

Net income for the third quarter of 2009 was $2.9 million, or $0.03 per share, compared to net income of $14.6 million, or $0.20 per share, for the third quarter of 2008.

Last Trade: 2.80
Trade Time: 10:05am ET
Change: Up 0.0899 (3.32%)
Prev Close: 2.71
Open: 2.99
Day’s Range: 2.60 – 2.99
52wk Range: 0.91 – 5.64
Volume: 44,155
Avg Vol (3m): 74,530.8
Market Cap: 199.73M

About Tiens Biotech Group USA Inc.

Tiens Biotech Group (USA), Inc., through its subsidiaries, engages in the research, development, manufacture, and marketing of nutrition supplement products. It offers wellness products and dietary supplement products in the form of powder, tea, capsules, tablets, granules, and soft gel capsules. The company sells its products primarily in the People’s Republic of China, Indonesia, the Russian Federation, Ukraine, India, Vietnam, Nigeria, Kazakhstan, Congo, Hungary, Kenya, and Peru through affiliated companies. Tiens Biotech Group is headquartered in Tianjin, the People’s Republic of China.